BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25744480)

  • 1. Rate of metastasis in examined lymph nodes as a predictor of extracapsular extension in patients with axillary node-positive breast cancer.
    Unal D; Oguz A; Tasdemir A
    J Nippon Med Sch; 2014; 81(6):372-7. PubMed ID: 25744480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.
    Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E
    Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
    Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
    Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of extracapsular extension of axillary lymph node metastases in breast cancer.
    Ilknur GB; Hilmi A; Tülay C; Oguz C; Selma S; Serdar S; Uğur Y; Pinar B; Omer H; Münir K;
    Tumori; 2004; 90(1):107-11. PubMed ID: 15143982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
    Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
    Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control?
    Stranzl H; Ofner P; Peintinger F
    Strahlenther Onkol; 2006 Oct; 182(10):583-8. PubMed ID: 17013571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy?
    Pierce LJ; Oberman HA; Strawderman MH; Lichter AS
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):253-9. PubMed ID: 7673012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracapsular extension is associated with increased ratio of metastatic to examined lymph nodes in axillary node-positive breast cancer.
    Gorgulu S; Can MF; Yagci G; Sahin M; Tufan T
    Clin Breast Cancer; 2007 Oct; 7(10):796-800. PubMed ID: 18021482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E-cadherin and syndecan-1 in axillary lymph node metastases of breast cancer with and without extracapsular extension.
    Thanakit V; Ruangvejvorachai P; Sampatanukul P
    J Med Assoc Thai; 2008 Jul; 91(7):1087-92. PubMed ID: 18839850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.
    Hetelekidis S; Schnitt SJ; Silver B; Manola J; Bornstein BA; Nixon AJ; Recht A; Gelman R; Harris JR; Connolly JL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):31-4. PubMed ID: 10656369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma.
    Oosterkamp S; de Jong JM; Van den Ende PL; Manni JJ; Dehing-Oberije C; Kremer B
    Laryngoscope; 2006 Nov; 116(11):2067-70. PubMed ID: 17075409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
    Coutant C; Rouzier R; Fondrinier E; Marchal F; Guillemin F; Seince N; Rodrigues A; Darai E; Uzan S; Barranger E
    Breast Cancer Res Treat; 2009 Feb; 113(3):537-43. PubMed ID: 18340527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
    Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
    J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden.
    Stitzenberg KB; Meyer AA; Stern SL; Cance WG; Calvo BF; Klauber-DeMore N; Kim HJ; Sansbury L; Ollila DW
    Ann Surg; 2003 May; 237(5):607-12; discussion 612-3. PubMed ID: 12724626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
    Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
    Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.